Literature DB >> 23062785

Historical trend of disparity implications of Medicare MTM eligibility criteria.

Junling Wang1, Yanru Qiao.   

Abstract

BACKGROUND: Non-Hispanic Blacks (Blacks) and Hispanics have a lower likelihood of being eligible for medication therapy management (MTM) services than do non-Hispanic Whites (Whites) based on Medicare MTM eligibility criteria.
OBJECTIVES: To determine whether MTM eligibility criteria would perform differently over time, this study examined the trend of MTM disparities from 1996-1997 to 2007-2008.
METHODS: The study populations were Medicare beneficiaries from the Medical Expenditure Panel Survey. Proportions and the odds of MTM eligibility were compared between Whites and ethnic minorities. The trend of disparities was examined by including in logistic regression models interaction terms between dummy variables for the minority groups and 2007-2008. MTM eligibility thresholds for 2008 and 2010-2011 were analyzed. Main and sensitivity analyses were conducted to represent the entire range of the eligibility criteria.
RESULTS: This study found no statistical significant racial or ethnic disparities associated with the MTM eligibility criteria for 2008 among the Medicare population during 1996-1997. However, racial disparities associated with 2010-2011 MTM eligibility criteria were significant according to multivariate analyses among the Medicare population during 1996-1997. During 2007-2008, both racial and ethnic disparities associated with both 2008 MTM eligibility criteria and 2010-2011 eligibility criteria were generally significant. Disparity patterns did not exhibit a statistically significant change from 1996-1997 to 2007-2008.
CONCLUSIONS: Racial and ethnic disparities in meeting MTM eligibility criteria may not decrease over time unless MTM eligibility criteria are changed.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Eligibility criteria; Ethnicity; Health disparities; Historical trend; Medication therapy management services; Race

Mesh:

Year:  2012        PMID: 23062785      PMCID: PMC3549304          DOI: 10.1016/j.sapharm.2012.09.003

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  25 in total

1.  Cost-effectiveness analysis of pharmaceutical care in a medicare drug benefit program.

Authors:  Lida R Etemad; Joel W Hay
Journal:  Value Health       Date:  2003 Jul-Aug       Impact factor: 5.725

2.  Where health disparities begin: the role of social and economic determinants--and why current policies may make matters worse.

Authors:  Steven H Woolf; Paula Braveman
Journal:  Health Aff (Millwood)       Date:  2011-10       Impact factor: 6.301

3.  Medicare as a catalyst for reducing health disparities.

Authors:  June Eichner; Bruce C Vladeck
Journal:  Health Aff (Millwood)       Date:  2005 Mar-Apr       Impact factor: 6.301

4.  Medicare program; Medicare prescription drug benefit. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2005-01-28

5.  Predictors of antidepressant use among older adults: have they changed over time?

Authors:  Dan G Blazer; Celia F Hybels; Gerda G Fillenbaum; Carl F Pieper
Journal:  Am J Psychiatry       Date:  2005-04       Impact factor: 18.112

6.  Disparities in access to essential new prescription drugs between non-Hispanic whites, non-Hispanic blacks, and Hispanic whites.

Authors:  Junling Wang; Jason M Noel; Ilene H Zuckerman; Nancy A Miller; Fadia T Shaya; C Daniel Mullins
Journal:  Med Care Res Rev       Date:  2006-12       Impact factor: 3.929

7.  Definition of medication therapy management: development of professionwide consensus.

Authors:  Benjamin M Bluml
Journal:  J Am Pharm Assoc (2003)       Date:  2005 Sep-Oct

8.  Marked differences in antidepressant use by race in an elderly community sample: 1986-1996.

Authors:  D G Blazer; C F Hybels; E M Simonsick; J T Hanlon
Journal:  Am J Psychiatry       Date:  2000-07       Impact factor: 18.112

9.  Racial disparities in prescription drug use among dually eligible beneficiaries.

Authors:  Jennifer Schore; Randall Brown; Bridget Lavin
Journal:  Health Care Financ Rev       Date:  2003

10.  Racial and ethnic disparities in prescription coverage and medication use.

Authors:  Becky Briesacher; Rhona Limcangco; Darrell Gaskin
Journal:  Health Care Financ Rev       Date:  2003
View more
  10 in total

1.  Trends in Medicare Part D Medication Therapy Management Eligibility Criteria.

Authors:  Junling Wang; Ya-Chen Tina Shih; Yolanda Qin; Theo Young; Zachary Thomas; Christina A Spivey; David K Solomon; Marie Chisholm-Burns
Journal:  Am Health Drug Benefits       Date:  2015 Jul-Aug

2.  Potential effects of racial and ethnic disparities in meeting Medicare medication therapy management eligibility criteria.

Authors:  Junling Wang; Yanru Qiao; Ya-Chen Tina Shih; Christina A Spivey; Samuel Dagogo-Jack; Jim Y Wan; Shelley I White-Means; William C Cushman; Marie A Chisholm-Burns
Journal:  J Pharm Health Serv Res       Date:  2014-06

3.  Disparity Implications of Proposed 2015 Medicare Eligibility Criteria for Medication Therapy Management Services.

Authors:  Junling Wang; Yanru Qiao; Christina A Spivey; Christine Li; Caroline Clark; Yuewen Deng; Flora Liu; Jeffrey Tillman; Marie Chisholm-Burns
Journal:  J Pharm Health Serv Res       Date:  2016-05-26

4.  Racial/ethnic disparities in the enrollment of Medication Therapy Management programs among Medicare beneficiaries with Alzheimer's disease and related dementias.

Authors:  Jamie A Browning; Chi Chun Steve Tsang; Rose Zeng; Xiaobei Dong; Joseph Garuccio; Jim Y Wan; Marie A Chisholm-Burns; Christopher K Finch; Jack W Tsao; Junling Wang
Journal:  Curr Med Res Opin       Date:  2022-08-09       Impact factor: 2.705

5.  Racial and ethnic disparities in meeting MTM eligibility criteria among patients with asthma.

Authors:  Degan Lu; Yanru Qiao; Karen C Johnson; Junling Wang
Journal:  J Asthma       Date:  2016-09-27       Impact factor: 2.515

6.  Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.

Authors:  Junling Wang; Yanru Qiao; Ya-Chen Tina Shih; JoEllen Jarrett-Jamison; Christina A Spivey; Jim Y Wan; Shelley I White-Means; Samuel Dagogo-Jack; William C Cushman; Marie Chisholm-Burns
Journal:  J Manag Care Spec Pharm       Date:  2015-11

7.  Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria.

Authors:  Junling Wang; Yanru Qiao; Ya-Chen Tina Shih; Jim Y Wan; Shelley I White-Means; Samuel Dagogo-Jack; William C Cushman
Journal:  Res Social Adm Pharm       Date:  2013-06-10

8.  Predictive Value Positive of MTM Eligibility Criteria under MMA and ACA in Identifying Individuals with Medication Utilization Issues.

Authors:  Yanru Qiao; Christina A Spivey; Junling Wang; Ya-Chen Tina Shih; Jim Y Wan; Julie Kuhle; Samuel Dagogo-Jack; William C Cushman; Marie Chisholm-Burns
Journal:  J Pharm Health Serv Res       Date:  2018-09-07

9.  Higher Predictive Value Positive for MMA Than ACA MTM Eligibility Criteria Among Racial and Ethnic Minorities: An Observational Study.

Authors:  Yanru Qiao; Christina A Spivey; Junling Wang; Ya-Chen Tina Shih; Jim Y Wan; Julie Kuhle; Samuel Dagogo-Jack; William C Cushman; Marie A Chisholm-Burns
Journal:  Inquiry       Date:  2018 Jan-Dec       Impact factor: 1.730

10.  Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.

Authors:  Christina A Spivey; Junling Wang; Yanru Qiao; Ya-Chen Tina Shih; Jim Y Wan; Julie Kuhle; Samuel Dagogo-Jack; William C Cushman; Marie Chisholm-Burns
Journal:  J Manag Care Spec Pharm       Date:  2018-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.